Among inappropriate overrides , the therapeutic combinations put patients at increased risk of several specific conditions including : serotonin syndrome ( 21.5 % , n = 34 ) , cardiotoxicity ( 16.5 % , n = 26 ) , or sharp falls in blood pressure or significant hypotension ( 28.5 % , n = 45 ) .